These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9541332)

  • 1. Clozapine reduces violence and persistent aggression in schizophrenia.
    Glazer WM; Dickson RA
    J Clin Psychiatry; 1998; 59 Suppl 3():8-14. PubMed ID: 9541332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of violent behavior among acute psychiatric patients: clinical study.
    Amore M; Menchetti M; Tonti C; Scarlatti F; Lundgren E; Esposito W; Berardi D
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):247-55. PubMed ID: 18588583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
    Hotham JE; Simpson PJ; Brooman-White RS; Basu A; Ross CC; Humphreys SA; Larkin F; Gupta N; Das M
    CNS Spectr; 2014 Oct; 19(5):403-10. PubMed ID: 24284256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national study of violent behavior in persons with schizophrenia.
    Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antipsychotic agents: emerging clinical profiles.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of clozapine in a mentally retarded and aggressive population.
    Cohen SA; Underwood MT
    J Clin Psychiatry; 1994 Oct; 55(10):440-4. PubMed ID: 7961521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia.
    Kranzler H; Roofeh D; Gerbino-Rosen G; Dombrowski C; McMeniman M; DeThomas C; Frederickson A; Nusser L; Bienstock MD; Fisch GS; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):55-63. PubMed ID: 15608544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Violence in schizophrenia and bipolar disorder.
    Volavka J
    Psychiatr Danub; 2013 Mar; 25(1):24-33. PubMed ID: 23470603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of violence in schizophrenia and implications for long-term treatment.
    Volavka J; Citrome L
    Int J Clin Pract; 2008 Aug; 62(8):1237-45. PubMed ID: 18564202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing clozapine treatment.
    Naber D
    J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional versus novel antipsychotics: changing concepts and clinical implications.
    Remington G; Chong SA
    J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.